Hainanenin-1, an Oncolytic Peptide, Triggers Immunogenic Cell Death Via STING Activation in Triple-negative Breast Cancer

Overview

Journal Cell Commun Signal

Publisher Biomed Central

Specialties Biochemistry
Cell Biology

Date 2024 Jul 5

PMID 38970078

Authors

Xiaoxi Li

Nan Su

Haining Yu

Xiaoyan Li

Shu-Lan Sun

Affiliations

Soon will be listed here.

Abstract

Background: In triple-negative breast cancer (TNBC) therapy, insufficient tumor infiltration by lymphocytes significantly hinders the efficacy of immune checkpoint inhibitors. We have previously demonstrated that Hainanenin-1 (HN-1), a host defense peptide (HDP) identified from Hainan frog skin, induces breast cancer apoptosis and boots anti-tumor immunity via unknown mechanism.

Methods: We used in vitro experiments to observe immunogenic cell death (ICD) indicators in HN-1-treated TNBC cell lines, a mouse tumor model to verify HN-1 promotion of mice anti-tumor immune response, and an in vitro drug sensitivity test of patient-derived breast cancer cells to verify the inhibitory effect of HN-1.

Results: HN-1 induced ICD in TNBC in a process during which damage-associated molecular patterns (DAMPs) were released that could further increase the anti-tumor immune response. The secretion level of interleukin 2 (IL-2), IL-12, and interferon γ in the co-culture supernatant was increased, and dendritic cells (DCs) were activated via a co-culture with HN-1-pretreated TNBC cells. As a result, HN-1 increased the infiltration of anti-tumor immune cells (DCs and T lymphocytes) in the mouse model bearing both 4T1 and EMT6 tumors. Meanwhile, regulatory T cells and myeloid-derived suppressor cells were suppressed. In addition, HN-1 induced DNA damage, and double-strand DNA release in the cytosol was significantly enhanced, indicating that HN-1 might stimulate ICD via activation of STING pathway. The knockdown of STING inhibited HN-1-induced ICD. Of note, HN-1 exhibited inhibitory effects on patient-derived breast cancer cells under three-dimensional culture conditions.

Conclusions: Collectively, our study demonstrated that HN-1 could be utilized as a potential compound that might augment immunotherapy effects in patients with TNBC.

References

Gatalica Z, Snyder C, Maney T, Ghazalpour A, Holterman D, Xiao N . Programmed cell death 1 (PD-1) and its ligand (PD-L1) in common cancers and their correlation with molecular cancer type. Cancer Epidemiol Biomarkers Prev. 2014; 23(12):2965-70. DOI: 10.1158/1055-9965.EPI-14-0654. View

Kobayashi H, Tanisaka K, Doi O, Kodama K, Higashiyama M, Nakagawa H . An in vitro chemosensitivity test for solid human tumors using collagen gel droplet embedded cultures. Int J Oncol. 2011; 11(3):449-55. DOI: 10.3892/ijo.11.3.449. View

Furlong S, Mader J, Hoskin D . Bovine lactoferricin induces caspase-independent apoptosis in human B-lymphoma cells and extends the survival of immune-deficient mice bearing B-lymphoma xenografts. Exp Mol Pathol. 2010; 88(3):371-5. DOI: 10.1016/j.yexmp.2010.02.001. View

Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

Zhang D, Liu Y, Zhu Y, Zhang Q, Guan H, Liu S . A non-canonical cGAS-STING-PERK pathway facilitates the translational program critical for senescence and organ fibrosis. Nat Cell Biol. 2022; 24(5):766-782. DOI: 10.1038/s41556-022-00894-z. View

Lu X, Wang X, Cheng H, Wang X, Liu C, Tan X . Anti-triple-negative breast cancer metastasis efficacy and molecular mechanism of the STING agonist for innate immune pathway. Ann Med. 2023; 55(1):2210845. PMC: 10173802. DOI: 10.1080/07853890.2023.2210845. View

Miyazaki R, Anayama T, Hirohashi K, Okada H, Kume M, Orihashi K . In Vitro Drug Sensitivity Tests to Predict Molecular Target Drug Responses in Surgically Resected Lung Cancer. PLoS One. 2016; 11(4):e0152665. PMC: 4829246. DOI: 10.1371/journal.pone.0152665. View

Gui X, Yang H, Li T, Tan X, Shi P, Li M . Autophagy induction via STING trafficking is a primordial function of the cGAS pathway. Nature. 2019; 567(7747):262-266. PMC: 9417302. DOI: 10.1038/s41586-019-1006-9. View

Luen S, Virassamy B, Savas P, Salgado R, Loi S . The genomic landscape of breast cancer and its interaction with host immunity. Breast. 2016; 29:241-50. DOI: 10.1016/j.breast.2016.07.015. View

10.

Demaria O, de Gassart A, Coso S, Gestermann N, Di Domizio J, Flatz L . STING activation of tumor endothelial cells initiates spontaneous and therapeutic antitumor immunity. Proc Natl Acad Sci U S A. 2015; 112(50):15408-13. PMC: 4687570. DOI: 10.1073/pnas.1512832112. View

11.

Hancock R, Nijnik A, Philpott D . Modulating immunity as a therapy for bacterial infections. Nat Rev Microbiol. 2012; 10(4):243-54. DOI: 10.1038/nrmicro2745. View

12.

Mansour S, Pena O, Hancock R . Host defense peptides: front-line immunomodulators. Trends Immunol. 2014; 35(9):443-50. DOI: 10.1016/j.it.2014.07.004. View

13.

Scott M, Dullaghan E, Mookherjee N, Glavas N, Waldbrook M, Thompson A . An anti-infective peptide that selectively modulates the innate immune response. Nat Biotechnol. 2007; 25(4):465-72. DOI: 10.1038/nbt1288. View

14.

Garcia Garcia M, Casares N, Martinez Perez L, Juarez Curiel E, de Jesus Hernandez A, Bogdanchikova N . Silver nanoparticles induce a non-immunogenic tumor cell death. J Immunotoxicol. 2023; 20(1):2175078. DOI: 10.1080/1547691X.2023.2175078. View

15.

Garrido-Castro A, Lin N, Polyak K . Insights into Molecular Classifications of Triple-Negative Breast Cancer: Improving Patient Selection for Treatment. Cancer Discov. 2019; 9(2):176-198. PMC: 6387871. DOI: 10.1158/2159-8290.CD-18-1177. View

16.

Roers A, Hiller B, Hornung V . Recognition of Endogenous Nucleic Acids by the Innate Immune System. Immunity. 2016; 44(4):739-54. DOI: 10.1016/j.immuni.2016.04.002. View

17.

Wang T, Li X, Sun S . EX527, a Sirt-1 inhibitor, induces apoptosis in glioma via activating the p53 signaling pathway. Anticancer Drugs. 2019; 31(1):19-26. DOI: 10.1097/CAD.0000000000000824. View

18.

Goto N, Westcott P, Goto S, Imada S, Taylor M, Eng G . SOX17 enables immune evasion of early colorectal adenomas and cancers. Nature. 2024; 627(8004):636-645. DOI: 10.1038/s41586-024-07135-3. View

19.

Gao D, Li T, Li X, Chen X, Li Q, Wight-Carter M . Activation of cyclic GMP-AMP synthase by self-DNA causes autoimmune diseases. Proc Natl Acad Sci U S A. 2015; 112(42):E5699-705. PMC: 4620884. DOI: 10.1073/pnas.1516465112. View

20.

Luo P, Shi Z, He C, Chen G, Feng J, Zhu L . Predicting the Clinical Outcome of Triple-Negative Breast Cancer Based on the Gene Expression Characteristics of Necroptosis and Different Molecular Subtypes. Stem Cells Int. 2023; 2023:8427767. PMC: 10234373. DOI: 10.1155/2023/8427767. View